Family communication after genetic testing for colon cancer
Part of Cancer, Digestive system clinical trials.
This trial studies how patients with newly diagnosed colon cancer share genetic test results with their family members. It aims to improve communication and support after learning about hereditary risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have been diagnosed with stage I to IV colon or rectal cancer within the last 3 months.
- You need at least 2 living family members (parents, children, or siblings) who are 18 or older and live in the U.S.
- You must be willing to share your cancer diagnosis with those family members.
- You cannot have had genetic testing for hereditary cancer in the past 2 years, or have a known hereditary colon cancer syndrome.
- You must be able to read and speak either English or Spanish.
- You must not have dementia, a cognitive impairment, or a condition that would make it hard to understand genetic test results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple blood test to look for tiny bits of tumor DNA after colon cancer surgery. If found, it may help doctors catch any remaining cancer early and guide further treatment.
This study looks at ways to better predict how colon cancer will behave after surgery. By understanding your cancer better, doctors hope to tailor treatment and follow-up, which could improve your outcome.
This study measures “minimal residual disease,” meaning tiny amounts of cancer that may remain after surgery, using blood samples. It may help doctors better detect who is at higher risk of cancer coming back and guide follow-up care.
This Phase 1 study uses a blood test called ctDNA to decide whether and how to adjust treatment in people with colon cancer who still have a small amount of disease left after surgery. If your blood test remains positive, the trial aims to reduce recurrence risk by guiding treatment changes.
This study looks at genetic reasons some families get colon cancer due to inherited (run-in-the-family) syndromes. It may help doctors better understand risk and tailor care for you or your relatives.
This study tests new educational materials about genetic testing for cancer patients. It aims to find the best ways to explain genetic testing to people from different backgrounds, especially Black, Latino, and non-Latino non-Black communities.
Hear when a new Rectal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.